We have a clinical trial that is looking at treatment for people with certain gene changes in their myeloma cells, whose myeloma has come back or treatment has stopped working.
BUBBLE trial
Chief investigator -
Professor Kwee Yong, University College London
Myeloma
A phase Ib study of BKM120 with bortezomib in defined genetic subgroups of patients with relapsed or refractory multiple myeloma
Some people have gene changes in their myeloma cells, causing them to not respond well to standard chemotherapy as well as other treatments. This group of people are also more likely to see their myeloma return. There is a great need to develop new drugs for people with poor outcomes.
We are supporting a clinical trial called BUBBLE, which is looking at a treatment for myeloma that has stopped responding to treatment, or has returned.